Evaluation of efficacy, safety and tolerability of valdecoxib in osteo-arthritis patients - An Indian study

Journal of the Indian Medical Association

Volumn 100, Issue 11, 2002, Pages 673-674

  Jagtap, S A ^a   Lahoti, Satish ^b   Anwaruddin, K ^c   Ram, S ^d   Ballary, Chetna ^e   Desai, Anish ^e  

^a SIR J J GROUP OF HOSPITALS   (India)

^b M R MEDICAL COLLEGE   (India)

^c Zubeda Hospital   (India)

^d Kumaran Hospitals (P) Limited   (India)

^e Glenmark Pharmaceuticals Limited   (India)

Author keywords

Osteo arthritis; Valdecoxib

Indexed keywords

VALDECOXIB; ISOXAZOLE DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFONAMIDE;

ABDOMINAL PAIN; ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INDIA; JOINT STIFFNESS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE WEAKNESS; NAUSEA; OSTEOARTHRITIS; PAIN ASSESSMENT; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; VERTIGO; VISUAL ANALOG SCALE; VOMITING; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; ANALYSIS OF VARIANCE; DOUBLE BLIND PROCEDURE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANALYSIS OF VARIANCE; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDIA; ISOXAZOLES; MALE; MIDDLE AGED; OSTEOARTHRITIS; PROSPECTIVE STUDIES; SULFONAMIDES;

EID: 0037563817     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Gabriel SE, Jaakkimainen L, Bombardier C - Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Ann Intern Med 1991; 115: 787-96.
2. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, et al - Cyclooxygenase in biology and disease. Faseb J 1998; 12: 1063-73.
3. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al - Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000; 343: 1520-8.
4. Silverstein FE, Faich G, Goldstein JL, et al - Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS Study: a randomized controlled trial. JAMA 2000; 284: 1247-55.
5. Altman R, Asch E, Bloch G, Bole G, Borenstein D, Brandt K, et al - The American College of Rheumatology criteria for the classification and reportings of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-49.
6. Bellamy N - WOMAC Osteoarthritis Index: A User's Guide. New York: The Western Ontario and McMaster's Universities, 1995: 302-34.
7. Amin AR, Attur M, Patel RN, Thakker GD, Marshall PJ, Rediske J, et al - Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage:influence of nitric oxide. J Clin Invest 1997; 99: 1231-7.